Abstract
Postnatal bone formation is influenced by nutritional status and compromised by disturbances in metabolism. The oxidation of dietary lipids represents a critical source of ATP for many cells but has been poorly studied in the skeleton, where the prevailing view is that glucose is the primary energy source. Here, we examined fatty acid uptake by bone and probed the requirement for fatty acid catabolism during bone formation by specifically disrupting the expression of carnitine palmitoyltransferase 2 (Cpt2), an obligate enzyme in fatty acid oxidation, in osteoblasts and osteocytes. Radiotracer studies demonstrated that the skeleton accumulates a significant fraction of postprandial fatty acids, which was equal to or in excess of that acquired by skeletal muscle or adipose tissue. Female, but not male, Cpt2 mutant mice exhibited significant impairments in postnatal bone acquisition, potentially due to an inability of osteoblasts to modify fuel selection. Intriguingly, suppression of fatty acid utilization by osteoblasts and osteocytes also resulted in the development of dyslipidemia and diet-dependent modifications in body composition. Taken together, these studies demonstrate a requirement for fatty acid oxidation during bone accrual and suggest a role for the skeleton in lipid homeostasis.
| Original language | English |
|---|---|
| Article number | e92704 |
| Journal | JCI insight |
| Volume | 2 |
| Issue number | 16 |
| DOIs | |
| State | Published - Aug 17 2017 |
Bibliographical note
Publisher Copyright:© 2017 American Society for Clinical Investigation. All rights reserved.
Funding
We are indebted to Nadine Forbes-McBean in the Johns Hopkins University Phenotyping Core. This work was supported by NIH grants DK099134 to RCR, NS072241 to MJW, and DK090166 to EEK and a Merit Review grant (BX001234) from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development to TLC. TLC is also the recipient of a Research Career Scientist Award from the Department of Veterans Affairs. Support was also provided by the JHU-UMD Diabetes Research Center (DK079637).
| Funders | Funder number |
|---|---|
| JHU-UMD Diabetes Research Center | DK079637 |
| National Institutes of Health (NIH) | DK099134, NS072241, DK090166, BX001234 |
| National Institutes of Health (NIH) | |
| National Institute of Diabetes and Digestive and Kidney Diseases | P60DK079637 |
| National Institute of Diabetes and Digestive and Kidney Diseases | |
| U.S. Department of Veterans Affairs | |
| Biomedical Laboratory Research and Development, VA Office of Research and Development | |
| The Johns Hopkins University |
ASJC Scopus subject areas
- General Medicine